Publication Date:
1979-11-30
Description:
Resting Burkitt's lymphoma cells (Daudi) in culture are more sensitive targets for the antiproliferative activity of purified human fibroblast interferon than cells that are rapidly multiplying. Thus, interferon may be of significant clinical value in neoplasms involving stem cells and, after chemotherapy, in suppressing the reemergence of tumors.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Horoszewicz, J S -- Leong, S S -- Carter, W A -- New York, N.Y. -- Science. 1979 Nov 30;206(4422):1091-3.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/493995" target="_blank"〉PubMed〈/a〉
Keywords:
Burkitt Lymphoma/drug therapy/pathology
;
Cell Cycle/drug effects
;
Cell Division/*drug effects
;
Cell Line
;
Cells, Cultured
;
Humans
;
Interferons/*pharmacology/therapeutic use
;
Lymphocytes/drug effects
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink